FDA Inspection 1132756 — Fred Hutchinson Cancer Research Center - IRB
The FDA completed an inspection of Fred Hutchinson Cancer Research Center - IRB on October 19, 2020 in Seattle, WA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- October 19, 2020
- Fiscal Year
- 2021
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Seattle, WA (United States)
Additional Details
IRB